DE69714778D1 - Immunohistochemischer nachweis des proliferativen zustandes von karzinoma - Google Patents
Immunohistochemischer nachweis des proliferativen zustandes von karzinomaInfo
- Publication number
- DE69714778D1 DE69714778D1 DE69714778T DE69714778T DE69714778D1 DE 69714778 D1 DE69714778 D1 DE 69714778D1 DE 69714778 T DE69714778 T DE 69714778T DE 69714778 T DE69714778 T DE 69714778T DE 69714778 D1 DE69714778 D1 DE 69714778D1
- Authority
- DE
- Germany
- Prior art keywords
- carcinoma
- sample
- immunohistochemical detection
- proliferative state
- expression product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/779,870 US5846739A (en) | 1995-12-05 | 1997-01-06 | Immunohistochemical detection assay for carcinoma proliferative status |
PCT/US1997/020998 WO1998030907A1 (en) | 1997-01-06 | 1997-11-18 | Immunohistochemical detection assay for carcinoma proliferative status |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69714778D1 true DE69714778D1 (de) | 2002-09-19 |
DE69714778T2 DE69714778T2 (de) | 2003-04-10 |
Family
ID=25117836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69714778T Expired - Fee Related DE69714778T2 (de) | 1997-01-06 | 1997-11-18 | Immunohistochemischer nachweis des proliferativen zustandes von karzinoma |
Country Status (12)
Country | Link |
---|---|
US (1) | US5846739A (de) |
EP (1) | EP0958500B1 (de) |
JP (1) | JP3336016B2 (de) |
AT (1) | ATE222366T1 (de) |
AU (1) | AU712949B2 (de) |
CA (1) | CA2271092C (de) |
DE (1) | DE69714778T2 (de) |
DK (1) | DK0958500T3 (de) |
ES (1) | ES2182140T3 (de) |
IL (1) | IL129766A (de) |
NZ (1) | NZ335535A (de) |
WO (1) | WO1998030907A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6517513B1 (en) | 1999-01-21 | 2003-02-11 | Neomatrix, Llc | Intraductal breast fluid aspiration device |
US7034132B2 (en) | 2001-06-04 | 2006-04-25 | Anderson David W | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
WO2001077682A1 (fr) * | 2000-04-10 | 2001-10-18 | Institut Bioorganicheskoi Khimii Imeni Akademikov M.M. Shemyakina I Ju. A. Ovchinnikova Rossiisskoi Akademii Nauk | Anticorps diriges contre le facteur hldf, procedes de fabrication correspondants, peptides avec des capacites antigeniques et a hydrolyse hk et procede de diagnostic de l'etat anaplasique de cellules humaines |
US6866994B2 (en) | 2001-05-30 | 2005-03-15 | Neomatrix, Llc | Noninvasive intraductal fluid diagnostic screen |
DE10230631A1 (de) * | 2002-07-02 | 2004-01-22 | Metagen Pharmaceuticals Gmbh | Verwendungen von an Ngal bindenden Substanzen zur Diagnose und Behandlung von Krebserkrankungen |
CN101203759A (zh) | 2005-03-30 | 2008-06-18 | 普渡研究基金会 | 使用细胞叶酸维生素受体定量法而用于癌症预后的方法 |
US20100105150A1 (en) * | 2008-10-24 | 2010-04-29 | Abbott Laboratories | Isolated human autoantibodies to neutrophil gelatinase-associated lipocalin (ngal) and methods and kits for the detection of human autoantibodies to ngal |
WO2010054025A1 (en) * | 2008-11-05 | 2010-05-14 | Abbott Laboratories | Neutrophil gelatinase-associated lipocalin (ngal) protein isoforms enriched from urine and recombinant chinese hamster ovary (cho) cells and related compositions, antibodies, and methods of enrichment, analysis and use |
EP2710041A4 (de) | 2011-05-18 | 2014-11-05 | Parkinson S Inst | Assay zur bestimmung der lrrk2-aktivität bei morbus parkinson |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996024065A1 (en) * | 1995-02-03 | 1996-08-08 | Oncogene Science, Inc. | Methods for the detection of pro-cathepsins and uses thereof |
US5627034A (en) * | 1995-12-05 | 1997-05-06 | Wisconsin Alumni Research Foundation | Assay for carcinoma proliferative status by measuring NGAL expression level |
-
1997
- 1997-01-06 US US08/779,870 patent/US5846739A/en not_active Expired - Fee Related
- 1997-11-18 CA CA002271092A patent/CA2271092C/en not_active Expired - Fee Related
- 1997-11-18 AU AU55867/98A patent/AU712949B2/en not_active Ceased
- 1997-11-18 ES ES97952197T patent/ES2182140T3/es not_active Expired - Lifetime
- 1997-11-18 IL IL12976697A patent/IL129766A/en not_active IP Right Cessation
- 1997-11-18 DE DE69714778T patent/DE69714778T2/de not_active Expired - Fee Related
- 1997-11-18 DK DK97952197T patent/DK0958500T3/da active
- 1997-11-18 JP JP53085298A patent/JP3336016B2/ja not_active Expired - Fee Related
- 1997-11-18 NZ NZ335535A patent/NZ335535A/xx unknown
- 1997-11-18 AT AT97952197T patent/ATE222366T1/de not_active IP Right Cessation
- 1997-11-18 WO PCT/US1997/020998 patent/WO1998030907A1/en active IP Right Grant
- 1997-11-18 EP EP97952197A patent/EP0958500B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US5846739A (en) | 1998-12-08 |
DK0958500T3 (da) | 2002-10-07 |
JP2000508074A (ja) | 2000-06-27 |
ES2182140T3 (es) | 2003-03-01 |
CA2271092C (en) | 2004-02-10 |
EP0958500A1 (de) | 1999-11-24 |
CA2271092A1 (en) | 1998-07-16 |
AU5586798A (en) | 1998-08-03 |
IL129766A (en) | 2002-02-10 |
WO1998030907A1 (en) | 1998-07-16 |
ATE222366T1 (de) | 2002-08-15 |
EP0958500B1 (de) | 2002-08-14 |
NZ335535A (en) | 2000-08-25 |
DE69714778T2 (de) | 2003-04-10 |
AU712949B2 (en) | 1999-11-18 |
JP3336016B2 (ja) | 2002-10-21 |
IL129766A0 (en) | 2000-02-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60228684D1 (de) | System zur überwachung der konzentration von analyten in körperflüssigkeiten | |
ATE328278T1 (de) | Sammelapparat für einschrittigen test von mundflüssigkeiten | |
DE69928809D1 (de) | Differentielle diagnose von neurodegeneration | |
DE69838389D1 (de) | Regeneration von biosensoren | |
NO20010011L (no) | Optisk sensor for in-situ-måling av analytter | |
DE69716589D1 (de) | Quantitative immunochromatographische assays | |
AU2004256206A1 (en) | Device and method for simultaneous carrying out of blood group determination, serum cross-check and antibody detection test | |
CA2530052A1 (en) | System and method for analyte measurement using dose sufficiency electrodes | |
AU2003243558A8 (en) | Test strip for detection of analyte and methods of use | |
AU2001272327A1 (en) | Method and device for detecting substances in body fluids by raman spectroscopy | |
DE50209636D1 (de) | Messvorrichtung und -verfahren zur Bestimmung von Parametern medizinischer Flüssigkeiten | |
BR9507690A (pt) | Detecção de reticulócitos | |
DE69330067D1 (de) | Analytische testvorrichtung einschliesslich negativ- und positivkontrolle | |
BG104275A (en) | Method and device for express analysis of tested parameters in biological samples | |
ATE267399T1 (de) | Verfahren zum nachweis von komplex-gebundenem prostata-spezifischem antigen (kpsa) | |
WO2002057787A3 (en) | Detection of survivin in the biological fluids of cancer patients | |
ATE222366T1 (de) | Immunohistochemischer nachweis des proliferativen zustandes von karzinoma | |
DE69535273D1 (de) | Detektionsvorrichtung und -verfahren | |
IL142971A0 (en) | S100 proteins and autoantibodies as serum markers for cancer | |
DE69636749D1 (de) | Methode zur bestimmung von proteinfragmenten in körperflüssigkeiten | |
ATE282831T1 (de) | Verfahren zur diagnose von sepsis unter bestimmung löslicher cytokeratinfragmente | |
EP1563308A4 (de) | Verfahren und kits zur tumorigenizitätsdiagnose | |
DE50103032D1 (de) | Verfahren zur Diagnose von Sepsis unter Bestimmung von CA 19-9 | |
TW369411B (en) | Disposal electrode test block for current-type non-enzymatic uric acid test, its process and application | |
DE60320821D1 (de) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8339 | Ceased/non-payment of the annual fee |